Ioxaglic acid
C24H21I6N5O8 — CID 3742
View drug profile → ioxaglic acidData last refreshed: (MolForge compound catalog, from PubChem)
About Ioxaglic acid
Ioxaglic acid (PubChem CID 3742) has the molecular formula C24H21I6N5O8 and a molecular weight of 1268.88 g/mol. Its IUPAC name is 3-[[2-[[3-[acetyl(methyl)amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoyl]amino]acetyl]amino]-5-(2-hydroxyethylcarbamoyl)-2,4,6-triiodobenzoic acid.
Molecular Properties
| Compound Name | Ioxaglic acid |
|---|---|
| PubChem CID | 3742 |
| Molecular Formula | C24H21I6N5O8 |
| Molecular Weight | 1268.88 g/mol |
| Exact Mass | 1268.57 |
| IUPAC Name | 3-[[2-[[3-[acetyl(methyl)amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoyl]amino]acetyl]amino]-5-(2-hydroxyethylcarbamoyl)-2,4,6-triiodobenzoic acid |
| SMILES | CNC(=O)c1c(I)c(C(=O)NCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NCCO)c2I)c(I)c(N(C)C(C)=O)c1I |
| InChI | InChI=1S/C24H21I6N5O8/c1-7(37)35(3)20-17(29)10(21(39)31-2)13(25)11(18(20)30)23(41)33-6-8(38)34-19-15(27)9(22(40)32-4-5-36)14(26)12(16(19)28)24(42)43/h36H,4-6H2,1-3H3,(H,31,39)(H,32,40)(H,33,41)(H,34,38)(H,42,43) |
| InChIKey | TYYBFXNZMFNZJT-UHFFFAOYSA-N |
| XLogP | 3.45 |
| TPSA | 194.24 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1268.88 |
| LogP ≤ 5 | 3.45 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Related Compounds
Frequently Asked Questions
Browse: Molecules: I · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 3742 — identifiers, structure, computed properties (public domain)
- DrugCentral drug card 1472 — approved-drug record (CC BY-SA 4.0)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.